tm
Seeing Is Believing
tm
Seeing Is Believing
Sierra Oncology's activity chart (see below) currently has 18 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 74.17% with an average time for these price targets to be met of 81.25 days.
Most recent stock forecast was given by from OPPENHEIMER on 14-Apr-2022. First documented stock forecast 23-Oct-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Jan-2022
$55
$0.01 (0.02%)
$45
4 years 3 months ago
(14-Apr-2022)
2/3 (66.67%)
$0.25 (0.46%)
50
Buy Since 23-Oct-2017
$39
$-15.99 (-29.08%)
$80
4 years 3 months ago
(14-Apr-2022)
1/2 (50%)
$-15.75 (-28.77%)
2
Buy Since 22-Jun-2021
$55
$0.01 (0.02%)
$51
4 years 3 months 1 days ago
(13-Apr-2022)
4/5 (80%)
$0.25 (0.46%)
139
Buy Since 28-Sep-2021
$39
$-15.99 (-29.08%)
4 years 7 months 13 days ago
(01-Dec-2021)
2/2 (100%)
$15.72 (67.53%)
134
What is SRRA (Sierra Oncology) average time for price targets to be met?
Which analyst has the current highest performing score on SRRA (Sierra Oncology) with a proven track record?
Which analyst has the most public recommendations on SRRA (Sierra Oncology)?
Which analyst is the currently most bullish on SRRA (Sierra Oncology)?
Which analyst is the currently most reserved on SRRA (Sierra Oncology)?
